Showing results (381-390 of 476) with videos related to
Sort By:
Pageof 48
Infection & Chemotherapy|November 23, 2013
Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation centerJae-Cheol Kwon, Si-Hyun Kim, Jae-Ki Choi, et al.Mediators of Inflammation|January 24, 2015
Quercetin protects against obesity-induced skeletal muscle inflammation and atrophyNgoc Hoan Le, Chu-Sook Kim, Taesun Park, et al.BMC Infectious Diseases|October 30, 2013
Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective studySung-Yeon Cho, Dong-Gun Lee, Su-Mi Choi, et al.Biochemical and Biophysical Research Communications|June 25, 2013
Insect peptide CopA3-induced protein degradation of p27Kip1 stimulates proliferation and protects neuronal cells from apoptosisSeung Taek Nam, Dae Hong Kim, Min Bum Lee, et al.Clinical Drug Investigation|September 7, 2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive AspergillosisJohan A Maertens, Galia Rahav, Dong-Gun Lee, et al.Journal of Microbiology (Seoul, Korea)|September 11, 2004
DD1.5k, the gene preferentially expressed in bloodstream isolates of vancomycin-resistant Enterococcus faeciumSeung-Han Kim, Dong-Gun Lee, Jin-Hong Yoo, et al.Scandinavian Journal of Gastroenterology|October 19, 2010
Endosonographic features of esophageal granular cell tumors using a high-frequency catheter probeDong Uk Kim, Gwang Ha Kim, Dong Yup Ryu, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 12, 2011
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patientsSi-Hyun Kim, Dong-Seok Yim, Su-Mi Choi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2025
Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial StudyRaeseok Lee, Nayoun Kim, Won-Bok Kim, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2023
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical ConditionsRobert G Feldman, Raffaele Antonelli-Incalzi, Katie Steenackers, et al.Pageof 48